Excess bone marrow B-cells in patients with multiple myeloma achieving complete remission following autologous stem cell transplantation is a biomarker for improved survival

Br J Haematol. 2011 Nov;155(4):509-11. doi: 10.1111/j.1365-2141.2011.08700.x. Epub 2011 May 3.
No abstract available

Publication types

  • Letter

MeSH terms

  • Adult
  • Aged
  • B-Lymphocytes / immunology
  • B-Lymphocytes / pathology*
  • Biomarkers, Tumor
  • Bone Marrow Cells / immunology
  • Bone Marrow Cells / pathology*
  • Female
  • Hematopoietic Stem Cell Transplantation*
  • Humans
  • Kaplan-Meier Estimate
  • Male
  • Middle Aged
  • Multiple Myeloma / immunology
  • Multiple Myeloma / pathology*
  • Multiple Myeloma / surgery*
  • Survival Analysis

Substances

  • Biomarkers, Tumor